MENU
INM
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
InMed Pharmaceuticals (INM) Ownership - Who owns InMed Pharmaceuticals?
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company... Show more
Profile
Industry
N/A
Address
815 West Hastings Street
Phone
+1 604 669-7207
Employees
15
Web
https://www.inmedpharma.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
4.13M
P/E Ratio
0.01
Total Cash
4.68M
Projected Growth
N/A
Total Debt
848.59K
Revenue
4.92M
Risk (Beta)
0.33
Dividend Yield
N/A
Total Cash/Share
3.88
Total Debt/Equity
N/A
Revenue/Share
6.81 USD as % of share price
Fundamentals
INM
Capitalization
4.13M
P/E Ratio
0.01
Risk (Beta)
0.33
Dividend Yield
N/A
Total Cash
4.68M
Total Cash/Share
3.88
Total Debt
849K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.81%
Revenue
4.92M
ROE
N/A
Book Value
7.02M
P/B Ratio
0.58
Cash Flow
N/A
Earnings
-11.65
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
87.5M
Current Ratio
3.49
Current Revenue Per Employee
95400.00
Dividends Per Share - Security
N/A
EBITDA
-7.86M
Float
N/A
Float - Current
N/A
Gross Income Margin
13.92
Revenue To Assets
-73.43
Shares Held By Institutions
50K
Shares Outstanding - Current
1.21M
Total Liabilities
2.26M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-26.362
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
815 West Hastings Street
Phone
+1 604 669-7207
Employees
15
Web
https://www.inmedpharma.com